The glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Ozempic, Wegovy) enhances taste sensitivity, changes brain responses to sweet tastes, and may even alter expression of genes in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback